biometric as a service in healthcare market insights, continuous glucose monitoring devices market size, continuous glucose monitoring devices market share, continuous glucose monitoring devices market growth, continuous glucose monitoring devices market forecast, continuous glucose monitoring devices market analysis
What are the recent trends in market size and growth for the continuous glucose monitoring devices market?
The continuous glucose monitoring devices market size has grown rapidly in recent years. It will grow from $8.41 billion in 2024 to $9.86 billion in 2025 at a compound annual growth rate (CAGR) of 17.22%. The growth in the historic period can be attributed to increased patient safety and improved health outcomes, increased demand for diabetes management devices, increased the use of CGM devices, a rise in the number of diabetes patients, and increased patient trust.
The continuous glucose monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $18.45 billion in 2029 at a compound annual growth rate (CAGR) of 16.96%. The growth in the forecast period can be attributed to increasing healthcare spending, increasing awareness, increasing number of diabetes cases, increasing prevalence of diabetes, and rising popularity of continuous glucose monitoring devices. Major trends in the forecast period include technological advancements, innovations in CGM technology, mergers and acquisitions, regulatory approvals, and partnerships and collaborations.
Get Your Free Sample of The Global Continuous Glucose Monitoring Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20733&type=smp
How have varous drivers impacted the growth of the continuous glucose monitoring devices market?
The increasing prevalence of diabetes is expected to propel the growth of the continuous glucose monitoring devices market going forward. Diabetes is a condition where the body is unable to properly regulate blood sugar levels, either due to insufficient insulin production or insulin resistance. The rise in diabetes is largely due to factors like poor diet, sedentary lifestyles, obesity, aging populations, and genetic predisposition. Continuous glucose monitoring (CGM) devices help manage diabetes by providing real-time data on blood glucose levels, enabling timely adjustments to treatment and lifestyle. For instance, in March 2024, according to the Office for Health Improvement & Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Therefore, the increasing prevalence of diabetes is driving the growth of the continuous glucose monitoring devices market.
What are the primary segments of the continuous glucose monitoring devices market?
The continuous glucose monitoring devices market covered in this report is segmented –
1) By Component: Transmitters, Sensors, Receivers
2) By Connectivity: Bluetooth, 4G
3) By Demography: Child Population, Adult Population
4) By Application: Gestational Diabetes, Type-2 Diabetes, Type-1 Diabetes
5) By End-Use: Hospitals, Homecare Settings, Other End Users
Subsegments:
1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters, Integrated Transmitter-Receiver Systems
2) By Sensors: Enzyme-Based Sensors, Electrochemical Sensors, Non-Invasive Sensors
3) By Receivers: Mobile Device Integration (Smartphone Receivers), Standalone Receivers, Cloud-Based Data Sync Receivers
Order your report now for swift delivery
Which firms are leading the continuous glucose monitoring devices market?
Major companies operating in the continuous glucose monitoring devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton Dickinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., Nemaura Medical Inc.
How will industry trends affect the trajectory of the continuous glucose monitoring devices market?
Major companies are operating in the continuous glucose monitoring devices market, focusing on developing innovative technologies, such as over-the-counter continuous glucose monitors, to enhance accessibility, accuracy, and ease of use for users in managing blood glucose levels. An over-the-counter continuous glucose monitor is a device that allows individuals to track their blood glucose levels continuously without needing a prescription. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched a Lingo continuous glucose monitoring (CGM) system designed to provide users with real-time glucose data. The device offers real-time, continuous glucose monitoring, providing users with instant feedback on their blood sugar levels throughout the day. It features a sleek, user-friendly design with easy-to-read displays and integrates seamlessly with mobile apps for tracking trends and receiving alerts.
Which geographic trends are shaping the continuous glucose monitoring devices market, and which region has the highest market share?
North America was the largest region in the continuous glucose monitoring devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous glucose monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Continuous Glucose Monitoring Devices Market Report 2025 Offer?
The continuous glucose monitoring devices market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Continuous glucose monitoring (CGM) devices track blood sugar levels in real time via a sensor under the skin. They provide continuous data, trend insights, and alerts for highs and lows, helping manage diabetes effectively. These devices reduce the need for frequent finger pricks and enhance glucose control.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20733
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
